{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:54Z","timestamp":1790627994830,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC94-2320-B-182A-020"],"award-info":[{"award-number":["NSC94-2320-B-182A-020"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG 33139, CMRPG 331393, CMRPG 3D0391-3"],"award-info":[{"award-number":["CMRPG 33139, CMRPG 331393, CMRPG 3D0391-3"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12929-018-0474-9","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:55:51Z","timestamp":1538711751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yah-Huei","family":"Wu-Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chao","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chih","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Hsueh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ray","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"474_CR1","first-page":"81e8","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81e8.","journal-title":"J Med Genet"},{"key":"474_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","volume":"61","author":"KP Boyd","year":"2009","unstructured":"Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol. 2009;61:1\u201314.","journal-title":"J Am Acad Dermatol"},{"key":"474_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009;123:124\u201333.","journal-title":"Pediatrics"},{"key":"474_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/jnnp.2010.206532","volume":"10","author":"RE Ferner","year":"2010","unstructured":"Ferner RE. The neurofibromatoses. Pract Neurol. 2010;10:82\u201393.","journal-title":"Pract Neurol"},{"key":"474_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","volume":"105","author":"K DeBella","year":"2000","unstructured":"DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608\u201314.","journal-title":"Pediatrics"},{"key":"474_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med."},{"key":"474_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2001","unstructured":"Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the gap. Cell. 2001;104:593\u2013604.","journal-title":"Cell"},{"key":"474_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2009.11.FOCUS09221","volume":"28","author":"ON Gottfried","year":"2010","unstructured":"Gottfried ON, Viskochil D, Couldwell WT. Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Neurosurg Focus. 2010;28:1\u20139.","journal-title":"Neurosurg Focus"},{"key":"474_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","volume":"62","author":"GF Xu","year":"1990","unstructured":"Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990;62:599\u2013608.","journal-title":"Cell"},{"key":"474_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/356713a0","volume":"356","author":"TN Basu","year":"1992","unstructured":"Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature. 1992;356:713\u20135.","journal-title":"Nature"},{"key":"474_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/088307380201700804","volume":"17","author":"D Viskochil","year":"2002","unstructured":"Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol. 2002;17:562\u201370 discussion 571\u2013572, 646\u2013651.","journal-title":"J Child Neurol"},{"key":"474_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62:193\u2013201.","journal-title":"Cell"},{"key":"474_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/humu.10299","volume":"23","author":"L Kluwe","year":"2004","unstructured":"Kluwe L, Siebert R, Gesk S, Friedrich RE, Tinschert S, Kehrer-Sawatzki H, et al. Screening 500 unselected neurofibromatosis type 1 patients for deletions of the NF1 gene. Hum Mutat. 2004;23:111\u20136.","journal-title":"Hum Mutat"},{"key":"474_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","volume":"6","author":"S Griffiths","year":"2007","unstructured":"Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years\u2019 experience. Familial Cancer. 2007;6:21\u201334.","journal-title":"Familial Cancer"},{"key":"474_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gcc.20289","volume":"45","author":"K Wimmer","year":"2006","unstructured":"Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer. 2006;45:265\u201376.","journal-title":"Genes Chromosomes Cancer"},{"key":"474_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/jmg.2007.053785","volume":"44","author":"A De Luca","year":"2007","unstructured":"De Luca A, Bottillo I, Dasdia MC, Morella A, Lanari V, Bernardini L, et al. Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet. 2007;44:800\u20138.","journal-title":"J Med Genet"},{"key":"474_CR17","first-page":"63","volume-title":"Monographs in Human Genetics","author":"LM Messiaen","year":"2008","unstructured":"Messiaen LM, Wimmer K. NF1 mutational spectrum. Neurofibromatoses. In: Kaufmann D, editor. Monographs in Human Genetics, vol. 16. Basel: Karger; 2008. p. 63\u201377."},{"key":"474_CR18","doi-asserted-by":"publisher","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010;31:E1506\u201318.","journal-title":"Hum Mutat"},{"key":"474_CR19","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanch\u00e9 H, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510\u20138.","journal-title":"Hum Mutat"},{"key":"474_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cge.12187","volume":"85","author":"R van Minkelen","year":"2014","unstructured":"van Minkelen R, van Bever Y, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85:318\u201327.","journal-title":"Clin Genet"},{"key":"474_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/jhg.2015.6","volume":"60","author":"A Imbard","year":"2015","unstructured":"Imbard A, Pasmant E, Sabbagh A, Luscan A, Soares M, Goussard P, et al. NF1 single and multi-exons copy number variations in neurofibromatosis type 1. J Hum Genet. 2015;60:221\u20134.","journal-title":"J Hum Genet"},{"key":"474_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/mgg3.161","volume":"3","author":"D Bianchessi","year":"2015","unstructured":"Bianchessi D, Morosini S, Saletti V, Ibba MC, Natacci F. Esposito S, et al. 126 novel mutations in Italian patients with neurofibromatosis type 1. Mol Genet Genomic Med. 2015;3:513\u201325.","journal-title":"Mol Genet Genomic Med"},{"key":"474_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/humu.20748","volume":"29","author":"Y Aoki","year":"2008","unstructured":"Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat. 2008;29:992\u20131006.","journal-title":"Hum Mutat"},{"key":"474_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"E Tidyman","year":"2009","unstructured":"Tidyman E, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"474_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355\u201369.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"474_CR26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1086\/302809","volume":"66","author":"R Fahsold","year":"2000","unstructured":"Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, K\u00fcc\u00fckceylan N, et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000;66:790\u2013818.","journal-title":"Am J Hum Genet"},{"key":"474_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","volume":"13","author":"MC Valero","year":"2011","unstructured":"Valero MC, Mart\u00edn Y, Hern\u00e1ndez-Imaz E, Marina Hern\u00e1ndez A, Mele\u00e1n G, Valero AM, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn. 2011;13:113\u201322.","journal-title":"J Mol Diagn"},{"key":"474_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pediatrneurol.2013.02.004","volume":"48","author":"JM Ko","year":"2013","unstructured":"Ko JM, Sohn YB, Jeong SY, Kim HJ, Messiaen LM. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1. Pediatr Neurol. 2013;48:447\u201353.","journal-title":"Pediatr Neurol"},{"key":"474_CR29","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2340\/00015555-1843","volume":"94","author":"E Uusitalo","year":"2014","unstructured":"Uusitalo E, Hammais A, Palonen E, Brandt A, M\u00e4kel\u00e4 VV, Kallionp\u00e4\u00e4 R, et al. Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing. Acta Derm Venereol. 2014;94:663\u20136.","journal-title":"Acta Derm Venereol"},{"key":"474_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12031-014-0286-7","volume":"53","author":"B Balla","year":"2014","unstructured":"Balla B, \u00c1rvai K, Horv\u00e1th P, Tobi\u00e1s B, Tak\u00e1cs I, Nagy Z, et al. Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene. J Mol Neurosci. 2014;53:204\u201310.","journal-title":"J Mol Neurosci"},{"key":"474_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/gtmb.2014.0109","volume":"18","author":"R Maruoka","year":"2014","unstructured":"Maruoka R, Takenouchi T, Torii C, Shimizu A, Misu K, Higasa K, et al. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study. Genet Test Mol Biomarkers. 2014;18:722\u201335.","journal-title":"Genet Test Mol Biomarkers"},{"key":"474_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ejhg.2014.145","volume":"23","author":"E Pasmant","year":"2015","unstructured":"Pasmant E, Parfait B, Luscan A, Goussard P, Briand-Suleau A, Laurendeau I, et al. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet. 2015;23:596\u2013601.","journal-title":"Eur J Hum Genet"},{"key":"474_CR33","doi-asserted-by":"crossref","unstructured":"Zhang J, Tong H, Fu X, Zhang Y, Liu J, Cheng R, et al. Molecular characterization of NF1 and neurofibromatosis type 1 genotype-phenotype correlations in a Chinese population. Sci Rep 2015; 5: 11291.","DOI":"10.1038\/srep11291"},{"key":"474_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/genes7120133","volume":"7","author":"KS Cunha","year":"2016","unstructured":"Cunha KS, Oliveira NS, Fausto AK, de Souza CC, Gros A, Bandres T, et al. Hybridization capture-based next-generation sequencing to evaluate coding sequence and deep Intronic mutations in the NF1 gene. Genes (Basel). 2016;7:133.","journal-title":"Genes (Basel)"},{"key":"474_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"474_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/WNL.0000000000000652","volume":"83","author":"DH Gutmann","year":"2014","unstructured":"Gutmann DH. Eliminating barriers to personalized medicine. Neurology. 2014;83:463\u201371.","journal-title":"Neurology"},{"key":"474_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ejim.2014.04.004","volume":"25","author":"G Tadini","year":"2014","unstructured":"Tadini G, Milani D, Menni F, Pezzani L, Sabatini C, Esposito S. Is it time to change the neurofibromatosis 1 diagnostic criteria? Eur J Intern Med. 2014;25:506\u201310.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"474_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.pcl.2010.07.002","volume":"57","author":"KN Shah","year":"2010","unstructured":"Shah KN. The diagnostic and clinical significance of caf\u00e9-au-lait macules. Pediatr Clin N Am. 2010;57(5):1131\u201353.","journal-title":"Pediatr Clin N Am"},{"key":"474_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nm0306-283","volume":"12","author":"M Bentires-Alj","year":"2006","unstructured":"Bentires-Alj M, Kontaridis MI, Neel BG. Stops along the RAS pathway in human genetic disease. Nat Med. 2006;12:283\u20135.","journal-title":"Nat Med"},{"issue":"11","key":"474_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.055772","volume":"45","author":"E Denayer","year":"2008","unstructured":"Denayer E, de Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet 2008; 45: 695\u2013703.","journal-title":"Journal of Medical Genetics"},{"key":"474_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295\u2013308.","journal-title":"Nat Rev Cancer"},{"key":"474_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/504394","volume":"79","author":"C Carta","year":"2006","unstructured":"Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, et al. Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet. 2006;79:129\u201335.","journal-title":"Am J Hum Genet"},{"key":"474_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, B\u00f6ll S, Klein C, Bollag G, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331\u20136.","journal-title":"Nat Genet"},{"key":"474_CR44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jmg.2007.050450","volume":"44","author":"C Nava","year":"2007","unstructured":"Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, et al. Cardiofacio-cutaneous and Noonan syndromes due to mutations in RAS\/MAPK signaling pathway: genotype\/phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007;44:763\u201371.","journal-title":"J Med Genet"},{"key":"474_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/jmg.2006.046300","volume":"44","author":"M Zenker","year":"2007","unstructured":"Zenker M, Lehmann K, Schulz AL, Barth H, Hansmann D, Koenig R, et al. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet. 2007;44:131\u20135.","journal-title":"J Med Genet"},{"key":"474_CR46","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00431-008-0858-z","volume":"168","author":"FS Lo","year":"2009","unstructured":"Lo FS, Lin JL, Kuo MT, Chiu PC, Shu SG, Chao MC, et al. Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature. Eur J Pediatr. 2009;168:919\u201323.","journal-title":"Eur J Pediatr"},{"key":"474_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ng1749","volume":"38","author":"T Niihori","year":"2006","unstructured":"Niihori T, Aoki Y, Narumi Y, Neri G, Cav\u00e9 H, Verloes A, et al. Germline KRAS and BRAF mutations in cardio-facio- cutaneous syndrome. Nat Genet. 2006;38:294\u20136.","journal-title":"Nat Genet"},{"key":"474_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1126\/science.1124642","volume":"311","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006;311:1287\u201390.","journal-title":"Science"},{"key":"474_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.2007.00931.x","volume":"73","author":"AL Schulz","year":"2008","unstructured":"Schulz AL, Albrecht B, Arici C, van der Burgt I, Buske A, Gillessen-Kaesbach G, et al. Mutation and phenotypic spectrum in patients with cardio-Facio-cutaneous and Costello syndrome. Clin Genet. 2008;73:62\u201370.","journal-title":"Clin Genet"},{"key":"474_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/humu.20955","volume":"30","author":"A Sarkozy","year":"2009","unstructured":"Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat. 2009;30:695\u2013702.","journal-title":"Hum Mutat"},{"key":"474_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejmg.2009.04.006","volume":"52","author":"M Koudova","year":"2009","unstructured":"Koudova M, Seemanova E, Zenker M. Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence. Eur J Med Genet. 2009;52:337\u201340.","journal-title":"Eur J Med Genet"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-018-0474-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-018-0474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T19:09:38Z","timestamp":1570216178000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-018-0474-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1186\/s12929-018-0474-9","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethics approval was obtained by the institutional review board (102-0226A3) at the Chang Gung Memorial Hospital. Informed consent was individually obtained from all participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}